Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kohjin Bio CoTSE:177A -2.32%19 PB Ratio is 0.76 as of Aug. 06, 2026, which is 50% below its 10-year median of 1.51. GuruFocus rates TSE:177A with a GF Score™ of 19/100. The stock has 3 warning signs investors should review. Among 1,228 Biotechnology companies, Kohjin Bio Co ranks better than 87.13% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-06), Kohjin Bio Co's share price is 円885.00. Kohjin Bio Co's Book Value per Share for the quarter that ended in Mar. 2026 was 円1,162.99. Hence, Kohjin Bio Co's PB Ratio of today is 0.76.
Good Sign:
Kohjin Bio Co Ltd stock PB Ratio (=0.76) is close to 3-year low of 0.74.
The historical rank and industry rank for Kohjin Bio Co's PB Ratio or its related term are showing as below:
TSE:177A'
s PB Ratio Range Over the Past 10 Years
Min: 0.74 Med: 1.51 Max: 3.68
Current: 0.76
During the past 5 years, Kohjin Bio Co's highest PB Ratio was 3.68. The lowest was 0.74. And the median was 1.51.
TSE:177A's PB Ratio is ranked better than 87.13% of 1228
companies
in the Biotechnology industry
Industry Median: 2.85
vs TSE:177A: 0.76
During the past 12 months, Kohjin Bio Co's average Book Value Per Share Growth Rate was 2.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 24.60% per year.
During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Kohjin Bio Co was 36.80% per year. The lowest was 24.60% per year. And the median was 30.70% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Kohjin Bio Co PB Ratio Related Terms
Kohjin Bio Co PB Ratio Historical Data
* Premium members only.
The historical data trend for Kohjin Bio Co's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Kohjin Bio Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kohjin Bio Co PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kohjin Bio Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Kohjin Bio Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Kohjin Bio Co's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Kohjin Bio Co (TSE:177A) has a PB Ratio of 0.76 as of Aug. 06, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Kohjin Bio Co and its competitors. This is 50% below median its historical median of 1.51. Over the past decade, Kohjin Bio Co's PB Ratio has ranged from 0.74 to 3.68. According to the industry distribution chart, Kohjin Bio Co ranks #158 out of 1228 companies in the Biotechnology industry, placing it in the top 12.9%.
Is Kohjin Bio Co's PB Ratio too high?
Kohjin Bio Co's current PB Ratio of 0.76 is 50% below median its 10-year median of 1.51. Over the past 10 years, this metric has ranged from a low of 0.74 to a high of 3.68. The Biotechnology industry median PB Ratio is 2.85. Kohjin Bio Co's value of 0.76 is 73.3% below this industry median. Based on the distribution chart, Kohjin Bio Co ranks #158 out of 1228 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Kohjin Bio Co has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Kohjin Bio Co's PB Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kohjin Bio Co ranks #158 out of 1228 companies for PB Ratio. This places Kohjin Bio Co in the top 13% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.85. Kohjin Bio Co's value of 0.76 is 73.3% below this benchmark. Historically, Kohjin Bio Co's own PB Ratio has ranged from 0.74 to 3.68 over the past decade. While the company's 10-year median is 1.51 vs. the industry median of 2.85, Kohjin Bio Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.85, based on 1,228 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kohjin Bio Co's current PB Ratio of 0.76 is 73.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Kohjin Bio Co and its competitors. For the Biotechnology industry, the median PB Ratio is 2.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kohjin Bio Co's current PB Ratio is 0.76, which is 50% below median its own 10-year median of 1.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kohjin Bio Co stock overvalued right now?
Kohjin Bio Co (TSE:177A) has a current PB Ratio of 0.76. The current PB Ratio is 0.76, which is 50% below median its 10-year median of 1.51 and 73.3% below the Biotechnology industry median of 2.85. Kohjin Bio Co's overall GF Score™ is 19/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Kohjin Bio Co (TSE:177A), the current PB Ratio is 0.76 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kohjin Bio Co Ltd is engaged in development, manufacture and sale of culture media (growing environments used for culturing microorganisms and cells) and contract manufacturing of processed cell products. It has manufacturing and sales of animal blood, sera, tissue culture media, media for microbiology testing, in vitro diagnostic agents, and cosmetics.
19GF Score
Get the complete analysis for TSE:177A
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:177A has been successfully added to your 
